(Q40038968)

English

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

scientific article published on 21 November 2007

Statements

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase (English)
Bernard Barlaam
Robert H Bradbury
D Mark Hickinson
Teresa Klinowska
Françoise Magnien
Donald J Ogilvie
Stuart E Pearson
Cath B Trigwell
Michel Vautier
Robin D Whittaker

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit